DTIL – Precision BioSciences Inc.
DTIL — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
10.41
Margin Of Safety %
Put/Call OI Ratio
0.06
EPS Next Q Diff
EPS Last/This Y
0.81
EPS This/Next Y
0.56
Price
7.51
Target Price
29.4
Analyst Recom
1
Performance Q
0.13
Upside
-1,838.3%
Beta
1.24
Ticker: DTIL
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | DTIL | 8.57 | 0.21 | 0.03 | 1251 |
| 2026-07-14 | DTIL | 8.59 | 0.22 | 0.12 | 1235 |
| 2026-07-15 | DTIL | 8.79 | 0.21 | 2.13 | 1405 |
| 2026-07-16 | DTIL | 8.32 | 0.25 | 0.80 | 1470 |
| 2026-07-17 | DTIL | 7.85 | 0.26 | 0.06 | 1454 |
| 2026-07-20 | DTIL | 7.37 | 0.07 | 0.06 | 996 |
| 2026-07-21 | DTIL | 7.59 | 0.06 | 0.00 | 1014 |
| 2026-07-22 | DTIL | 7.34 | 0.06 | 0.00 | 1068 |
| 2026-07-23 | DTIL | 7.31 | 0.06 | 0.00 | 1074 |
| 2026-07-24 | DTIL | 7.28 | 0.06 | 0.00 | 1080 |
| 2026-07-27 | DTIL | 7.24 | 0.06 | 999.99 | 1079 |
| 2026-07-28 | DTIL | 7.16 | 0.07 | 999.99 | 1086 |
| 2026-07-29 | DTIL | 6.89 | 0.08 | 1.25 | 1094 |
| 2026-07-30 | DTIL | 7 | 0.07 | 0.00 | 1079 |
| 2026-07-31 | DTIL | 7 | 0.07 | 0.00 | 1080 |
| 2026-08-03 | DTIL | 7.06 | 0.07 | 0.00 | 1087 |
| 2026-08-04 | DTIL | 7.29 | 0.06 | 0.00 | 1149 |
| 2026-08-05 | DTIL | 7.49 | 0.06 | 0.00 | 1149 |
| 2026-08-06 | DTIL | 7.4 | 0.06 | 0.06 | 1200 |
| 2026-08-07 | DTIL | 7.52 | 0.06 | 0.06 | 1200 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | DTIL | 8.57 | 68.5 | - | -2.49 |
| 2026-07-14 | DTIL | 8.57 | 68.5 | - | -2.49 |
| 2026-07-15 | DTIL | 8.84 | 68.5 | - | -2.49 |
| 2026-07-16 | DTIL | 8.31 | 68.5 | - | -2.49 |
| 2026-07-17 | DTIL | 7.86 | 68.5 | - | -2.49 |
| 2026-07-20 | DTIL | 7.35 | 68.5 | - | -2.49 |
| 2026-07-21 | DTIL | 7.59 | 68.5 | - | -2.49 |
| 2026-07-22 | DTIL | 7.33 | 68.5 | - | -2.49 |
| 2026-07-23 | DTIL | 7.32 | 68.5 | - | -2.49 |
| 2026-07-24 | DTIL | 7.29 | 68.5 | - | -2.49 |
| 2026-07-27 | DTIL | 7.25 | 68.5 | - | -2.49 |
| 2026-07-28 | DTIL | 7.17 | 68.5 | - | -2.49 |
| 2026-07-29 | DTIL | 6.90 | 68.5 | - | -2.49 |
| 2026-07-30 | DTIL | 7.02 | 68.5 | - | -2.49 |
| 2026-07-31 | DTIL | 7.00 | 68.5 | - | -2.49 |
| 2026-08-03 | DTIL | 7.05 | 68.5 | - | -2.49 |
| 2026-08-04 | DTIL | 7.05 | 68.5 | - | -2.49 |
| 2026-08-05 | DTIL | 7.48 | 68.5 | - | -2.49 |
| 2026-08-06 | DTIL | 7.41 | 68.5 | - | -2.49 |
| 2026-08-07 | DTIL | 7.51 | 67.5 | - | -2.75 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | DTIL | -3.58 | 2.73 | 10.02 |
| 2026-07-14 | DTIL | -3.58 | 2.73 | 10.02 |
| 2026-07-15 | DTIL | -3.58 | 2.73 | 10.02 |
| 2026-07-16 | DTIL | -3.58 | 2.73 | 10.02 |
| 2026-07-17 | DTIL | -3.58 | 2.73 | 10.02 |
| 2026-07-20 | DTIL | -3.58 | 2.64 | 10.02 |
| 2026-07-21 | DTIL | -3.58 | 2.64 | 10.02 |
| 2026-07-22 | DTIL | -3.58 | 2.64 | 10.02 |
| 2026-07-23 | DTIL | -1.31 | 2.64 | 10.02 |
| 2026-07-24 | DTIL | -1.31 | 2.64 | 10.02 |
| 2026-07-27 | DTIL | -1.31 | 5.25 | 10.41 |
| 2026-07-28 | DTIL | -1.31 | 5.25 | 10.41 |
| 2026-07-29 | DTIL | -1.31 | 5.25 | 10.41 |
| 2026-07-30 | DTIL | -1.31 | 5.25 | 10.41 |
| 2026-07-31 | DTIL | -1.31 | 5.25 | 10.41 |
| 2026-08-03 | DTIL | -1.31 | -0.08 | 10.41 |
| 2026-08-04 | DTIL | -1.31 | -0.08 | 10.41 |
| 2026-08-05 | DTIL | -1.31 | -0.08 | 10.41 |
| 2026-08-06 | DTIL | -1.31 | -0.08 | 10.41 |
| 2026-08-07 | DTIL | -1.31 | -0.08 | 10.41 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.69
Avg. EPS Est. Next Quarter
-0.67
Insider Transactions
-1.31
Institutional Transactions
-0.08
Beta
1.24
Average Sales Estimate Current Quarter
1
Average Sales Estimate Next Quarter
1
Fair Value
Quality Score
21
Growth Score
30
Sentiment Score
67
Actual DrawDown %
98.3
Max Drawdown 5-Year %
-99.2
Target Price
29.4
P/E
Forward P/E
PEG
P/S
4.29
P/B
2.54
P/Free Cash Flow
EPS
-3.72
Average EPS Est. Cur. Y
-2.75
EPS Next Y. (Est.)
-2.18
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-98.7
Relative Volume
0.56
Return on Equity vs Sector %
-100
Return on Equity vs Industry %
-100
EPS 1 7Days Diff
-0.3
EPS 1 30Days Diff
-0.26
EBIT Estimation
◆
DTIL
Healthcare
$7.49
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
50.3
Range 1M
26%
Sup Dist
5.9%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
13.2%
EPS NY
16.6%
52W%
64.4%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+292.5% upside
Upside
+292.5%
Quality
21
DTIL — P/E HistoricalBiotechnology
Precision BioSciences, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 67
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-DMD (Excision) for the treatment of Duchenne muscular dystrophy. In addition, the company develops PBGENE-3243 for the treatment of m.3243 associated mitochondrial diseases; and iECURE-OTC (Insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with TG Cell Therapy, Inc. to develop, manufacture, and commercialize azercabtagene zapreleucel for autoimmune diseases and other indications; and iECURE, Inc., an ARCUS-mediated targeted gene insertion. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
DTIL
Latest News
—
Caricamento notizie per DTIL…
stock quote shares DTIL – Precision BioSciences Inc. Stock Price stock today
news today DTIL – Precision BioSciences Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DTIL – Precision BioSciences Inc. yahoo finance google finance
stock history DTIL – Precision BioSciences Inc. invest stock market
stock prices DTIL premarket after hours
ticker DTIL fair value insiders trading